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Abstract 45 
Scope 46 
Antibiotic stewardship programmes (ASPs) are necessary in hospitals to improve the 47 
judicious use of antibiotics. While ASPs require complex change of key behaviours on 48 
individual, team, organisation and policy levels, evidence from the behavioural 49 
sciences is underutilised in antibiotic stewardship studies across the world, including 50 
high-income countries (HICs). A consensus procedure was performed to propose 51 
research priority areas for optimising effective implementation of ASPs in hospital 52 
settings, using a behavioural perspective.  53 
Methods 54 
A workgroup for behavioural approaches to ASPs was convened in response to the 55 
fourth call for leading expert network proposals by the Joint Programming Initiative 56 
on Antimicrobial Resistance (JPIAMR). Eighteen clinical and academic specialists in 57 
antibiotic stewardship, implementation science and behaviour change from four high-58 
income countries with publicly-funded health care systems (that is Canada, Germany, 59 
Norway and the UK), met face-to-face to agree on broad research priority areas using 60 
a structured consensus method. 61 
Question addressed and recommendations 62 
The consensus process on the 10 identified research priority areas resulted in 63 
recommendations that need urgent scientific interest and funding to optimise 64 
effective implementation of antibiotic stewardship programmes for hospital 65 
inpatients in HICs with publicly-funded health care systems. We suggest and detail, 66 
behavioural science evidence-guided research efforts in the following areas:  1) 67 
Comprehensively identifying barriers and facilitators to implementing antibiotic 68 
stewardship programmes and clinical recommendations intended to optimise 69 
antibiotic prescribing; 2) Identifying actors (‘who’) and actions (‘what needs to be 70 
done’) of antibiotic stewardship programmes and clinical teams; 3) Synthesising 71 
available evidence to support future research and planning for antibiotic stewardship 72 
programmes; 4) Specifying the activities in current antibiotic stewardship programmes 73 
with the purpose of defining a ‘control group’ for comparison with new initiatives; 5) 74 
3
Defining a balanced set of outcomes and measures to evaluate the effects of 75 
interventions focused on reducing unnecessary exposure to antibiotics; 6) Conducting 76 
robust evaluations of antibiotic stewardship programmes with built-in process 77 
evaluations and fidelity assessments; 7) Defining and designing antibiotic stewardship 78 
programmes; 8) Establishing the evidence base for impact of antibiotic stewardship 79 
programmes on resistance; 9) Investigating the role and impact of government and 80 
policy contexts on antibiotic stewardship programmes; and 10) Understanding what 81 
matters to patients in antibiotic stewardship programmes in hospitals. 82 
 Assessment, revisions and updates of our priority-setting exercise should be 83 
considered, at intervals of 2 years. To propose research priority areas in low- and 84 
medium income countries (LIMCs), the methodology reported here could be applied.    85 
 86 
 87 
  88 
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Scope 89 
The proposed overarching priority research areas are intended for researchers, 90 
representatives from funding agencies and policy-makers. These priorities provide 91 
suggestions on what needs urgent scientific interest and funding to optimise effective 92 
implementation of antibiotic stewardship programmes for hospital inpatients using 93 
theoretical and empirical evidence from behavioural sciences. We based those 94 
suggestions on experiences from high-income countries (HICs) with publicly-funded 95 
health care systems, where most evidence on antibiotic stewardship come from.  96 
Context 97 
Antibiotic resistance is a globally important problem associated with excess mortality, 98 
morbidity, prolonged hospital stays and increased healthcare costs [1]. Overuse or 99 
inappropriate use of antibiotics drives the development of antibiotic resistance [2]. 100 
The vast majority of human consumption of antibiotics occurs in primary-care settings 101 
and nursing homes [3], but antibiotic resistance has predominantly been a clinical 102 
problem in hospitals which are particularly susceptible to harbouring multidrug-103 
resistant organisms [4]. Therefore, antibiotic stewardship is essential to improve the 104 
judicious use of antibiotics in hospitals by providing practitioners with tools to 105 
prescribe effective therapy while reducing antibiotic-related adverse events, such as 106 
antibiotic resistance [1,4]. 107 
An antibiotic stewardship programme (ASP) is a coherent set of collective daily 108 
actions that promotes using antibiotic agents responsibly, where ‘action’ is defined as 109 
a strategy (i.e. a specific set of coherent interventions) [5]. In practice, ASPs involve a 110 
heterogeneous group of system- and organisation-based actions, so understandably 111 
there is not only substantial transnational variability in the development and 112 
implementation of ASPs [6], but even organisation-level variability in HICs [7-10]. This 113 
suggests a global need to optimise and standardise the implementation of ASPs. Co-114 
ordinated transnational response efforts are underway to enhance the 115 
implementation (i.e. uptake into practice and policy) of effective ASPs [4]. The 116 
planning of such large-scale quality improvement initiatives first requires optimising 117 
the use of existing research resource management [11]. The growing number of 118 
research projects on ASPs being conducted and submitted for publication 119 
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demonstrates that it is a priority area [12], but a number of important research gaps 120 
still need to be addressed [4]. Addressing high-importance questions (i.e. research 121 
priorities) will reduce avoidable research waste [11]. Core elements and checklist 122 
items for global ASPs, including in LIMCs where most of antibiotics are prescribed, 123 
have been developed [13], but without a behavioural ‘lens’. More robust qualitative 124 
research investigating contextual influences on ASPs is needed from LMICs to propose 125 
research priorities for those countries using behavioural ‘lens’. 126 
An antibiotic stewardship programme requires complex behaviour change; 127 
multiple healthcare providers are required to change multiple behaviours at different 128 
time points in the patient care pathway. Moreover, change is required at the 129 
individual, team, organisation and policy levels to change key behaviours. It has been 130 
widely recognised that evidence from behavioural science can be used to inform that 131 
change [3,4,14,15]. The underlying principle of this need is understanding the 132 
difference between recommendations for appropriate antibiotic use (the ‘what’) and 133 
behaviour change interventions (the ‘how’) [3]. To inform the development of a more 134 
effective health behaviour change intervention (that is a systematic interference 135 
designed to modify how an individual acts), researchers have started to specify the 136 
active ingredients of interventions in terms of their component behaviour change 137 
techniques (BCTs) [16]. BCTs are the observable, replicable components of behaviour 138 
change interventions. We know from a Cochrane review that interventions to improve 139 
the translation of antibiotic use recommendations into practice are effective in 140 
increasing compliance with antibiotic policy and reducing duration of antibiotic 141 
treatment in acute care hospital settings [14]. However, the review suggests that few 142 
of those interventions used effective behaviour change techniques (such as action 143 
planning or feedback), the role of a key stakeholder (i.e. junior doctors) is mostly 144 
overlooked, and interventions are developed at the local level on an ad hoc basis [14]. 145 
One of the main recommendations from the review included a need to bring together 146 
world experts in antibiotic stewardship in partnership with experts in implementation 147 
and social sciences to develop a research agenda to guide future research efforts to 148 
optimise effective implementation of ASPs in hospital settings [14].  149 
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Question addressed  150 
What are the research priority areas to optimise effective implementation of ASPs in 151 
hospital settings in HICs with publicly-funded health care systems?   152 
Methods 153 
Description of the development group 154 
A transnational multidisciplinary workgroup on behavioural approaches to ASPs was 155 
convened in response to the fourth call for leading experts’ network proposals of the 156 
Joint Programming Initiative on Antimicrobial Resistance (JPIAMR). The steering 157 
committee (CR, JMG, PGD) identified 16 members (all the other co-authors) through 158 
a process of peer knowledge sharing and consultation, through existing research 159 
networks and contacts. Members were invited on the basis of: 1) their recognised 160 
expertise in antibiotic stewardship, behavioural and implementation science, 161 
including clinical leads, senior academic staff or experts for health authorities or 162 
policy-makers, with at least 10 years of experience in their subject area or 2) being 163 
frontline clinical staff, clinical- academic or non-clinical academic staff with extensive 164 
experience in the above three areas and 3) coming from a high-income countries with 165 
publicly funded health care systems. In total, the group included 19 members from 166 
the UK (11), Germany (2), Norway (2) and Canada (4). The members had different 167 
backgrounds, including infectious disease physicians, nurses, researchers; 168 
implementation scientists; health psychologists; intervention design methodologists 169 
and health care service scientists (full list: Appendix 1- Supplementary materials 1).  170 
Consensus procedure  171 
The workgroup met face-to-face on the 27th - 28th April 2017 (in Birmingham, UK) 172 
and 30th- 31st October 2017 (in Aberdeen, UK). Meetings were audio-recorded and 173 
summarised and notes were taken. To ensure the priority-setting team had necessary 174 
information about the context [17], each meeting was guided by an agenda for 175 
activities, including practical group work and presentations of knowledge synthesis 176 
undertaken by the workgroup. The latter included: a non-systematic review and 177 
knowledge synthesis of existing evidence on ASP implementation efforts worldwide; 178 
a systematic review of multi-country studies on barriers and facilitators to ASPs in 179 
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hospitals (PROSPERO registration number CRD42017076425); and the Cochrane 180 
review of interventions to improve antibiotic prescribing to hospital inpatients [14].  181 
The stages of the priority setting process were informed by existing literature 182 
[18] and are summarised in Figure 1. We used the nominal group technique (NGT) - a 183 
commonly used formal consensus development method involving a highly structured 184 
face-to-face group interaction. Practical benefits for which we chose the NGT 185 
included: immediate dissemination of results to the group [19], giving equal voice to 186 
each participant by encouraging individual input [19], reduction of personality effects 187 
(e.g. influences of a power structure) and creating an environment conducive to 188 
initiation of change [20]. In our experience research needs within the area of 189 
behavioural approaches to ASPs are vast and intertwined. Also, in practice, specific 190 
research questions are likely to vary across systems and specific settings [8]. 191 
Therefore, similar to Healy and colleagues [21], we used a modified James Lind 192 
Alliance (JLA) process [22] that led to suggesting unique broad general prioritisation 193 
research areas rather than specific research questions.  194 
The process protocol is presented in the Supplementary Materials 1. The 195 
session began the workgroup coordinator (CR) with an introduction to the whole 196 
group and an explanation of the purpose of the activity. Participating members then 197 
split into two equal-sized groups. Each group was allocated one consensus decision-198 
making process facilitator (KG and EMD). Both have been previously involve in a 199 
consensus process, and one facilitator (KG) also had previous experiences with the JLA 200 
process. We selected facilitators with the skills to unite differing perspectives and 201 
spheres of expertise and enabling interaction [23]. To capture experiential differences 202 
in people with similar background, thereby giving rise to new perspectives, 203 
participants with similar areas of expertise were grouped together (e.g. experts in 204 
infectious diseases and health psychology and implementation). At the same time, to 205 
stimulate discussion, each group included sub-groups with at least three different 206 
areas of expertise and we also included a clinical-academic in each group. Participants 207 
were asked to generate specific research ideas in these groups. For this purpose, in 208 
silence, participants wrote down research ideas on provided sticky notes. They were 209 
instructed to write one idea per note and encouraged to use as many notes as needed. 210 
Each participant presented and brought their research ideas forward for discussion in 211 
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their groups by reading them aloud and explaining their choices. All ideas were 212 
collected, numbered and displayed on a flipchart board by a group facilitator. All 213 
participants were then asked to read the ideas generated by the other group. 214 
Participants were brought together through discussion and inductively 215 
collated overlapping research ideas into topics. In the JLA process of priority setting – 216 
a well-established framework – typically the main focus is to agree the list of the Top 217 
10 priorities for future research [22]. However, to avoid artificial consensus, the group 218 
was not informed about this specific number. Instead, we planned to offer the group 219 
an option to decide how many research priority topics would be carried forward for 220 
ranking and prepared a priori a strategy to reduce the number of generated topics if 221 
necessary (detailed in the Supplementary Materials 1).  222 
After a short break, each participant was provided with a printed copy of the 223 
prioritised research topics and asked to rank these priorities from most to least 224 
important. An e-polling system that collects and summarises responses was used to 225 
collate the ranking of the priority ideas. Responses were submitted using personal 226 
electronic devices. After an interval for another activity, the results were presented to 227 
the group on a large projection screen. A facilitator then guided the participants 228 
through listening to each idea, opinion, and concern and initiated discussion to reach 229 
consensus (i.e. a solution that everyone actively supports, or at least can accept). 230 
Results  231 
Consensus process 232 
The consensus process for research priority setting took place in Aberdeen in October 233 
2017 and lasted 2.5 hours. Sixteen members generated and collated research ideas 234 
into topics, of which fifteen (one person had to leave an activity early) ranked the 235 
prioritised research topics. Following discussion, the group spontaneously collated 236 
individually-generated overlapping research ideas into 10 research topics, hence there 237 
was no need to consider reducing the numbers of generated topics. During the 238 
discussion of the results of ranking of the prioritised research topics, the group 239 
concluded that the top five research priorities received similar ranking scores; priority 240 
research areas are inter-dependent, and so research is much needed across all ten.   241 
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The dynamic of each group was different, due to different personalities, 242 
experiences, expertise, backgrounds, communication styles and levels of confidence. 243 
The discussions were however vigorous and each participant took strong ownership 244 
of their own proposed ideas. The presence of a facilitator, with experience in both 245 
behavioural and implementation science, to moderate those discussions ensured 246 
mutual understanding. Placing individuals with similar background and prior 247 
presentations and group activities also facilitated shared understanding. In the next 248 
step, pragmatism was required to collate individual research ideas to reach acceptable 249 
compromises and revision of opinions in the search for consensus. At this point, the 250 
group required the assistance of the second facilitator and an administrator for record 251 
keeping, to ensure full, fair, respectful and equal participation. 252 
Recommendations 253 
Table 1 shows priorities and ranked research topics grouped into three main 254 
descriptive themes. Individual research ideas are presented in the Supplementary 255 
Materials 2. We would anticipate research teams to select the broad research areas 256 
prioritised and develop a specific research project from them. For example, one 257 
research objective for the top research priority would be: Developing a core outcome 258 
set, reflecting clinicians’ and patients’ views, to enable evaluation of effectiveness of 259 
an intervention to support behaviour change, specified (in terms of Target, Action, 260 
Context, Time, Actor (TACTA)), focused on reducing unnecessary exposure to 261 
antibiotics in hospital patients. Within the second top research priority topic, a specific 262 
research objective could be: Developing and piloting a multicentre, transnational, 263 
cluster-randomised controlled trial to compare short- and long-term effects of two 264 
ASPs with different BCT-specified antibiotic stewardship interventions in hospital 265 
inpatient settings. An example research objective within the third research topic: 266 
Estimating short- and long-term effects of TACTA-specified ASP behaviours on Gram-267 
negative and Gram-positive bacteria, using a controlled interventional study design 268 
and data-reporting. 269 
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Implications  270 
The main implication of this consensus work is potentially reducing avoidable waste 271 
and inefficiency in research by directing future research to address the proposed 272 
uncertainties of importance [23]. To facilitate this process, participation of a priority-273 
setting team in discussion with the community of interest, to share findings and 274 
experiences, is recommended [17]. Research teams are encouraged to identify 275 
opportunities for building robust proposals focused on comprehensively addressing 276 
research objectives within these priorities. Robust proposals could be informed by 277 
recommendations for avoiding research waste [11]; and guidance on designing and 278 
reporting of ASP intervention studies [24,25], implementation studies [26] and 279 
behaviour change interventions [27,28]. ASPs are a global concern, and hence best 280 
addressed by engaging existing research teams to collaborate internationally and 281 
contribute evidence to answer the prioritised research topics. The JPIAMR Virtual 282 
Research Institute has offered to provide a platform to achieve that by increasing 283 
coordination, improving visibility and facilitating knowledge exchange globally 284 
(https://www.jpiamr.eu/activities/jpiamr-virtual-research-institute/). A promising 285 
innovative solution for contributing generalisable evidence is ‘implementation 286 
laboratories’ [29] - such as for the one proposed for audit and feedback 287 
(http://www.ohri.ca/auditfeedback/). For ASPs this would involve a research team 288 
integrated into healthcare systems undertaking research projects directly relevant to 289 
the healthcare systems’ priorities for ASPs. This could offer a much-needed platform 290 
for moving forward from small-scale studies developed on an ad hoc basis, towards 291 
co-ordinated large-scale initiatives focusing on applied research, to develop, 292 
implement and evaluate theoretically-informed ASPs in different contexts. Sufficient 293 
and sustainable resources to support further research efforts are needed to take this 294 
agenda forward. According to Chalmers et al, “research funders have primary 295 
responsibility for reduction in waste resulting from decisions about what research to 296 
do” [23], hence should be encouraged to integrate set research priorities into their 297 
organisational plans, research strategies and funding calls [23].  298 
Our aim was to further optimise ASPs for hospital inpatients, based on 299 
experiences of research partners from HICs. Globally, the majority of prescribing takes 300 
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place in LIMICs [3]. We fully agree with proposals to advance antibiotic stewardship 301 
research in those countries [4,24] - as evident in the fact that most of our group 302 
members collaborate with research partners in LMICs. However, the health research 303 
capacity strengthening research field with a focus on implementation science is 304 
emerging, and currently evidence bases are not yet sufficiently advanced to effectively 305 
inform health research capacity strengthening research programme planning [30]. 306 
Based on our best knowledge and experiences, we recognised that implementation of 307 
ASPs varies greatly across types of healthcare systems, let alone LMICs, so inviting a 308 
limited number partners from LMICs was likely to unfairly prioritise specific research 309 
needs in their countries. We expect a similar consensus procedure to be conducted 310 
with a range of front-line clinicians and academics from LMICs with extensive 311 
experience with antibiotic prescribing in partnership with experts in implementation, 312 
intervention design and behavioural sciences from HICs and LMICs. More robust 313 
qualitative research investigating contextual influences on ASPs is needed from LMICs 314 
to inform such a consensus procedure. 315 
We did not include patients whose role in hospital antibiotic stewardship was 316 
traditionally limited, but now is starting to increase [31]. We anticipated that a major 317 
practical challenge to include patients would be a need to overcome patient-reported 318 
doubts on their ability to understand antibiotic use-related medical information [31]. 319 
We expect that including patients would affect the completeness of the prioritised 320 
areas; hence this is needed. As recommended by Nasser et al [17], improving and 321 
refining the proposed research priorities should be continued, so we encourage 322 
assessment, revisions and updates of our consensus process at intervals of 2 years, 323 
including involvement of other stakeholders (e.g. patients). Single systematic 324 
literature reviews around each priority topic could be conducted, where numbers and 325 
types of scientific publications could serve as a proxy to quantitatively assess the 326 
impact of our research priority areas. 327 
Conclusions 328 
We propose 10 research priorities areas - shared by clinicians, clinical and non-clinical 329 
academics from HICs with publicly-funded health care systems - for future research on 330 
hospital antibiotic stewardship programmes. For this we focused on a behavioural 331 
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science perspective – currently underutilised in antibiotic stewardship studies 332 
[3,14,15,32]. This way we addressed a recognised important gap in knowledge [14]. 333 
We specified how optimising implementation of ASPs will depend on the use of 334 
theoretical and empirical evidence from behavioural science for knowledge synthesis; 335 
investigation of implementation failures; informing the improved design and 336 
evaluation of effectiveness, sustainability and scalability of ASPs as quality 337 
improvement initiatives.  338 
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Figure 1 The stages of the research priorities setting process for antibiotic 360 
stewardship programmes in hospital settings. 361 
Table 1 The prioritised 10 research topics (an overarching aspiration: more impactful 362 
hospital antibiotic stewardship programmes). 363 
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